Author

Nichole Real Pelz

Observed name: Nichole Pelz

Institution: University of Washington

Observed institution: University of Washington

OpenAlex ID: A5033634015

ADAM trial: A multicenter, randomized, double-blinded, placebo-controlled, phase 3 trial of adjuvant avelumab (anti-PD-L1 antibody) in merkel cell carcinoma patients with clinically detected lymph node metastases; NCT03271372.

2018 · Shailender Bhatia, Andrew Scott Brohl, et al. · Journal of Clinical Oncology · 12

University of Washington/Seattle Cancer Care Alliance Experience with Single Agent Ipilimumab in Advanced Unresectable/Metastatic Melanoma

2015 · Nichole Real Pelz · ResearchWorks at the University of Washington (University of Washington)

Works count: 2

Citation count: 12

H-index: 1

I10-index: 1